XML 29 R19.htm IDEA: XBRL DOCUMENT ﻿
v2.3.0.11

Subsequent Events | 6 Months Ended
--- | ---
Jul. 03, 2011
Subsequent Events [Abstract] |
SUBSEQUENT EVENTS | NOTE 13 — SUBSEQUENT EVENTS On July 7, 2011, the Company completed the divestiture of its Animal Health business to Elanco, a Division of Eli Lilly. On July 14, 2011, the Company completed the acquisition of several over-the-counter cough and cold brands in Russia from J.B. Chemicals and Pharmaceuticals Ltd. On July 15, 2011, the Company announced the definitive agreement to divest the assets of its Ortho Dermatologics division in the U.S. to subsidiaries of Valeant Pharmaceuticals International, Inc.

X
- Details
Name: | us-gaap_SubsequentEventsAbstract
Namespace Prefix: | us-gaap
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business. + Details
Name: | us-gaap_SubsequentEventsTextBlock
Namespace Prefix: | us-gaap
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration